Norethindrone Acetate Tablet
Product Images NDC 0555-0211

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate (NDC 0555-0211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Norethindrone Acetate, showing the steroid backbone with acetate and ethynyl functional groups typical of this active ingredient.*

FDA Label Image

Image 2

A pharmacokinetic curve showing concentration (ng/mL) on the y-axis versus time (hours) on the x-axis, depicting drug concentration decline over a 36-hour period after administration.*

FDA Label Image

Image 3

Label for Norethindrone Acetate Tablets USP 5 mg by Teva Pharmaceuticals USA, Inc. The label states the tablets are orally active progestin, prescription only, with a package size of 50 tablets. Storage instructions and pharmacist dispensing note with patient information leaflet are included. The label shows NDC 0555-0211-10 and manufacturer details in North Wales, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.